A breakthrough made by researchers from the Technion (Israeli Tech University) may be the key to early diagnosis of cancer and other diseases.
The Israeli Technion University is a university for sciences and technology. The Technion demands excellence and discipline, and only the best students get in the university.
Because of their extremely high standards, the students and professors have yielded many successful projects and developments, including this one for early cancer diagnosis.
Several doctors, headed by Professor Arie Admon, from the Faculty of Biology, had developed a unique method for isolating a blood sample of short protein fragments that help identify the characteristics of the disease. The body shows these sections on the outer sides of the cells, to signal the immune system to destroy them.
This method allows researchers to collect the outer sections, which are proteins belonging to tissue matching, and then separate sections of the protein and look for typical sections including certain cancers, infections and other illnesses.
Professor Admon said it would take several years to develop an extensive medical application of the method, but it has been of great interest in the scientific and medical communities. The Technion also patented the development. The study is published on the PNAS journal, with an editorial explaining the importance of the development.
The people here in Israel are very proud of the development. Even as teenagers we know how important this is for people all over the world. We just hope it will help to reduce the number of the people who have or will have cancer.